- Country: Slovakia
- Summary: Medicines of the Atc Group L-Cytostatics and Immunomodulators_2 Description: the Subject of the Procurement is the Purchase of Medicines of the Atc Group L-Cytostatics and Immunomodulators Divided into 3 Parts: 1) Medicines with the Active Substa...
- SKT Ref No: 130303013
- Deadline: 27 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 50650.88
- Notice Type: Tender
- Document Ref. No.: 18158 - VST
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Medicines of the ATC group L-Cytostatics and immunomodulators_2 Description: The subject of the procurement is the purchase of medicines of the ATC group L-Cytostatics and immunomodulators, divided into 3 parts: 1) Medicines with the active substance Cyclophosphamide 2) Medicines with the active substance Dacarbazine 3) Medicines with the active substance Arsenic oxide Type of order: Goods 4.1.3 Scope of procurement Estimated value Estimated value (BT-27-Procedure) (value): 50,650.88 Estimated value (BT-27-Procedure) (currency): EuroMaximum value of framework agreementMaximum value of framework agreement (BT-271-Procedure) (value): 50,650.88Maximum value of framework agreement (BT-271-Procedure) (currency): EuroMain classificationType of classification: Common procurement dictionaryMain CPV code: Pharmaceutical productsInformation on the additional classification of the subject of the contractInformation on the additional classification of the subject of the contractClassification type: Common procurement dictionary4.1.4 Information about the place of fulfillment Information about the place of fulfillment Lower territorial unit of the country: Kosicky region Country: Slovakia4.2 Information about the procedure4.2.1 Procedure Type of procedure: Public competition5. Parts 5.1 Information about part 5.1.1 Part Name: 1 part) Medicines with the active substance Cyclophosphamide Part number: 1 Part from the context: 1 part) Medicines with the active substance Cyclophosphamide (LOT-0001) PurposeDescription of the partReference number: 26-VO/2025/RDFN_1Name: 1 part) Medicines with the active substance CyclophosphamideDescription: The subject of procurement is the purchase of ATC group L-Cytostatic drugs and immunomodulators divided into 3 parts: 1 part) Medicines with the active substance Cyclophosphamide, tablet obd (blis.Al/PVC/PVDC), 50mg-600 pieces The description of the subject of the contract is given in the tender documents published in the profile of the public proc... Disclaimer : This notice does not contain a specific deadline, so we assume 10 days from the date of publication, For a precise deadline and validity, please contact the purchasing authority
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicines of the Atc Group L-Cytostatics and Immunomodulators_2 Description: the Subject of the Procurement is the Purchase of Medicines of the Atc Group L-Cytostatics and Immunomodulators Divided into 3 Parts: 1) Medicines with the Active Substa... - Slovakia Tender
The CHILDREN'S FACULTY HOSPITAL KOSICE, a Government sector organization in Slovakia, has announced a new tender for Medicines of the Atc Group L-Cytostatics and Immunomodulators_2 Description: the Subject of the Procurement is the Purchase of Medicines of the Atc Group L-Cytostatics and Immunomodulators Divided into 3 Parts: 1) Medicines with the Active Substa.... This tender is published on SlovakiaTenders under SKT Ref No: 130303013 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-27.
The estimated tender value is EUR 50650.88, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
